Head and Neck Cancer TNM Staging
AJCC 8th Edition (Simplified Overview)
Disclaimer: This information is for educational purposes only and is a simplified representation of complex medical guidelines. It should NOT be used for clinical decision-making or patient care. Always refer to the latest official AJCC Staging Manual and consult with a qualified medical professional for accurate cancer staging and treatment.
General Principles of TNM Staging
TNM staging is a globally recognized system developed by the American Joint Committee on Cancer (AJCC) to describe the extent of cancer. It helps in prognosis, treatment planning, and research.
T (Tumor)
Describes the size and extent of the primary tumor.
- TX: Primary tumor cannot be assessed.
- T0: No evidence of primary tumor.
- Tis: Carcinoma in situ.
- T1-T4: Increasing size/local extension.
N (Nodes)
Indicates the presence and extent of regional lymph node involvement.
- NX: Nodes cannot be assessed.
- N0: No regional lymph node metastasis.
- N1-N3: Increasing involvement (number, size, extracapsular extension).
M (Metastasis)
Describes the presence of distant metastasis (spread to other parts of the body).
- M0: No distant metastasis.
- M1: Distant metastasis present.
The specific criteria for T, N, and M categories vary significantly by cancer site. Stage grouping (Stage 0-IV) combines these categories, often incorporating additional prognostic factors like HPV status, depth of invasion (DOI), and extracapsular extension (ECE).
1. Oral Cavity Cancer (Lip, Oral Cavity)
Key factor for T stage includes Depth of Invasion (DOI).
| Category | Description (Simplified) |
|---|---|
| T1 | Tumor ≤ 2 cm, DOI ≤ 5 mm |
| T2 | Tumor > 2 cm to ≤ 4 cm, or DOI > 5 mm to ≤ 10 mm |
| T3 | Tumor > 4 cm, or DOI > 10 mm, or bone erosion/tooth involvement |
| T4a | Moderately advanced local disease (e.g., bone destruction, deep extrinsic muscle) |
| T4b | Very advanced local disease (e.g., masticator space, skull base, internal carotid artery) |
| N (Nodes) - Standard for most sites | |
| N0 | No regional lymph node metastasis |
| N1 | Single ipsilateral node ≤ 3 cm, no Extracapsular Extension (ECE) |
| N2a | Single ipsilateral node > 3 cm to ≤ 6 cm, no ECE |
| N2b | Multiple ipsilateral nodes ≤ 6 cm, no ECE |
| N2c | Bilateral or contralateral nodes ≤ 6 cm, no ECE |
| N3 | Node > 6 cm, or any node with clinical or radiological ECE |
| M (Metastasis) - Standard for all sites | |
| M0 | No distant metastasis |
| M1 | Distant metastasis present |
2. Oropharynx Cancer
Crucial difference: Staging for oropharynx cancer significantly depends on HPV (Human Papillomavirus) status, which impacts prognosis. HPV-positive cancers have distinct N categories.
For HPV-Positive Oropharyngeal Cancer (p16-positive)
| Category | Description (Simplified) |
|---|---|
| T1 | Tumor ≤ 2 cm |
| T2 | Tumor > 2 cm to ≤ 4 cm |
| T3 | Tumor > 4 cm or extension to epiglottis |
| T4 | Tumor invades larynx, deep extrinsic muscle of tongue, medial pterygoid, or bone |
| N (Nodes) - Specific for HPV-Positive | |
| N0 | No regional lymph node metastasis |
| N1 | Any number of nodes, ≤ 6 cm in greatest dimension, ipsilateral, contralateral, or bilateral, all without ECE |
| N2 | Any node(s) with clinical or radiological ECE |
| M (Metastasis) - Standard for all sites | |
| M0 | No distant metastasis |
| M1 | Distant metastasis present |
For HPV-Negative Oropharyngeal Cancer (p16-negative)
Uses the standard T, N, M definitions similar to Oral Cavity.
| Category | Description (Simplified) |
|---|---|
| T1 | Tumor ≤ 2 cm |
| T2 | Tumor > 2 cm to ≤ 4 cm |
| T3 | Tumor > 4 cm or extension to epiglottis |
| T4a | Moderately advanced local disease (e.g., bone, deep/extrinsic muscle) |
| T4b | Very advanced local disease (e.g., masticator space, skull base, carotid artery) |
| N (Nodes) - Standard (Same as Oral Cavity N categories) | |
| N0 | No regional lymph node metastasis |
| N1 | Single ipsilateral node ≤ 3 cm, no ECE |
| N2a | Single ipsilateral node > 3 cm to ≤ 6 cm, no ECE |
| N2b | Multiple ipsilateral nodes ≤ 6 cm, no ECE |
| N2c | Bilateral or contralateral nodes ≤ 6 cm, no ECE |
| N3 | Node > 6 cm, or any node with clinical or radiological ECE |
| M (Metastasis) - Standard for all sites | |
| M0 | No distant metastasis |
| M1 | Distant metastasis present |
3. Larynx Cancer (Supraglottic Example)
Larynx cancer staging varies by subsite (glottic, supraglottic, subglottic). Here is a simplified example for the Supraglottic Larynx.
| Category | Description (Simplified) |
|---|---|
| T1 | Tumor limited to one subsite of supraglottis with normal vocal cord mobility |
| T2 | Tumor invades mucosa of more than one subsite of supraglottis, or adjacent sites (e.g., base of tongue, vallecula), with normal vocal cord mobility |
| T3 | Tumor limited to larynx with vocal cord fixation and/or invasion of postcricoid area, pre-epiglottic tissues |
| T4a | Tumor invades through thyroid cartilage, and/or into tissues beyond the larynx (e.g., trachea, soft tissues of neck, thyroid/cricoid cartilage erosion) |
| T4b | Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures |
| N (Nodes) - Standard (Same as Oral Cavity N categories) | |
| N0 | No regional lymph node metastasis |
| N1 | Single ipsilateral node ≤ 3 cm, no ECE |
| N2a | Single ipsilateral node > 3 cm to ≤ 6 cm, no ECE |
| N2b | Multiple ipsilateral nodes ≤ 6 cm, no ECE |
| N2c | Bilateral or contralateral nodes ≤ 6 cm, no ECE |
| N3 | Node > 6 cm, or any node with clinical or radiological ECE |
| M (Metastasis) - Standard for all sites | |
| M0 | No distant metastasis |
| M1 | Distant metastasis present |
4. Nasopharynx Cancer
Nasopharynx cancer often presents with distinct patterns of spread to regional lymph nodes compared to other head and neck sites.
| Category | Description (Simplified) |
|---|---|
| T1 | Tumor limited to nasopharynx |
| T2 | Tumor extends to oropharynx or nasal cavity without parapharyngeal extension |
| T3 | Tumor invades bony structures of skull base, paranasal sinuses, and/or invades parapharyngeal space |
| T4 | Tumor invades intracranial structures, cranial nerves, hypopharynx, orbit, or extends to infratemporal fossa |
| N (Nodes) - Specific for Nasopharynx | |
| N0 | No regional lymph node metastasis |
| N1 | Unilateral or bilateral cervical nodes ≤ 6 cm, and/or retropharyngeal nodes, all above the supraclavicular fossa |
| N2 | Bilateral cervical nodes ≤ 6 cm, all above the supraclavicular fossa |
| N3a | Node(s) > 6 cm in greatest dimension, above the supraclavicular fossa |
| N3b | Any node(s) in the supraclavicular fossa (including ipsilateral, contralateral, or bilateral involvement) |
| M (Metastasis) - Standard for all sites | |
| M0 | No distant metastasis |
| M1 | Distant metastasis present |
Comments
Post a Comment